RS Investments logo

RS Investments

North America, California, United States, San Francisco

Description

RS Investments have been delivering better client outcomes through research-driven active strategies

Investor Profile

RS Investments has made 8 investments, with 0 in the past 12 months and 13% as lead.

Stage Focus

  • Post Ipo Equity (63%)
  • Series B (13%)
  • Series E (13%)
  • Series A (13%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Clinical Trials
  • Home Health Care
  • Genetics
  • Health Diagnostics
  • Life Science
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does RS Investments frequently co-invest with?

Pura Vida Investments
North America, New York, United States, New York
Co-Investments: 2
Farallon Capital Management
North America, California, United States, San Francisco
Co-Investments: 2
dRx Capital
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Casdin Capital
North America, New York, United States, New York
Co-Investments: 2
Mubadala Capital Ventures
North America, California, United States, San Francisco
Co-Investments: 1
RTW Investments
North America, New York, United States, New York
Co-Investments: 2
BlackRock
North America, New York, United States, New York
Co-Investments: 1
LV
North America, New York, United States, New York
Co-Investments: 1
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 1
Lux Capital
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by RS Investments?

Better Therapeutics

San Francisco, California, United States

Better Therapeutics develops prescription software for treating cardiometabolic diseases.

Artificial Intelligence (AI)BiotechnologyHealth CaremHealthTherapeutics
Post Ipo EquityOct 29, 2021
Amount Raised: $70,000,000
Science 37

Culver City, California, United States

Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.

BiotechnologyClinical TrialsHealth CareHome Health Care
Post Ipo EquityOct 7, 2021
Amount Raised: $200,000,000
NeoGenomics

Fort Myers, Florida, United States

NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.

BiotechnologyGeneticsHealth CareHealth DiagnosticsMedicalPharmaceutical
Post Ipo EquityMay 5, 2021
Amount Raised: $200,000,000
Surface Oncology

Cambridge, Massachusetts, United States

Surface Oncology develops next-generation cancer immunotherapy treatments based on proprietary discoveries.

BiotechnologyHealth CareLife ScienceOncology
Post Ipo EquityMay 20, 2020
Amount Raised: $28,900,000
Cortexyme

South San Francisco, California, United States

Cortexyme is developing treatments for Alzheimer's and other degenerative disorders.

BiotechnologyHealth CareMedicalPharmaceutical
Series BMay 31, 2018
Amount Raised: $76,000,000
Lightwave Microsystems Corporation

San Jose, California, United States

A San Jose, Calif.-based integrated circuit maker

ElectronicsManufacturingTelecommunications
Series ENov 1, 2000
Amount Raised: $75,000,000
Four51

Minneapolis, Minnesota, United States

Four51 powers B2B eCommerce for thousands of businesses and millions of users worldwide.

B2BCloud InfrastructureDeveloper APIsE-CommerceE-Commerce Platforms
Series AJun 12, 2000
Amount Raised: $3,500,000
Sonic Foundry

Madison, Wisconsin, United States

Sonic Foundry offers video capture, management, and webcasting solutions to the education, business, and government sectors.

EducationInformation TechnologyVideo
Post Ipo EquityFeb 16, 2000
Amount Raised: $24,000,000